ProPhase Labs, Inc. Other Long-term Debt, Noncurrent
ProPhase Labs, Inc. (PRPH) had Other Long-term Debt, Noncurrent of $100.00 thousand as of 2015-09-30, per its 10-Q filed 2015-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:OtherLongTermDebtNoncurrent · last filed 2016-03-29
- 2015-09-30: Other Long-term Debt, Noncurrent $100.00K.
- 2015-06-30: Other Long-term Debt, Noncurrent $100.00K.
- 2014-12-31: Other Long-term Debt, Noncurrent $100.00K.
| Period end | Other Long-term Debt, Noncurrent |
|---|---|
| 2015-09-30 | $100.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $100.00K 10-Q · filed 2015-08-12 |
| 2014-12-31 | $100.00K 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |